
Similar efficacy with EACA and TXA for reduction of blood loss in patients undergoing TKA

Similar efficacy with EACA and TXA for reduction of blood loss in patients undergoing TKA
Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study
J Orthop Traumatol. 2019 Jul 18;20(1):28.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
3 studies (1691 patients) were included in this meta-analysis comparing EACA and TXA for the reduction of blood loss and transfusion requirement in total knee arthroplasty. The primary outcome of interest was blood loss and the amount of transfusion required. Secondary outcomes of interest included operative time, tourniquet time and complications. No significant differences were observed in all o...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Learn about our AI Driven
High Impact Search Feature

The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.